Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc.
US tuberculosis (TB) programs have helped to identify those with TB and latent TB infection and ensure they completed treatment; FDA advisers instructed that the COVID-19 vaccine Americans will ...
Every year on March 24 we mark World Tuberculosis Day, yet most of us still think, “TB happens to someone else.” But the ...